Inhibrx Biosciences, Inc. — Institutional Ownership
Which tracked institutions hold INBX, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
18
Funds holding
$214605514
Total value held
Buying
14 added/new · 3 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | $84916798 | 1263078 | +95350 | +8.17% |
| 2 | Blackrock, Inc. | $53709896 | 798898 | +21515 | +2.77% |
| 3 | State Street Corp | $37033309 | 550845 | +175884 | +46.91% |
| 4 | Goldman Sachs Group Inc | $10862621 | 161574 | -5543 | -3.32% |
| 5 | Invesco Ltd. | $8879284 | 112396 | +94822 | +539.56% |
| 6 | Northern Trust Corp | $6299182 | 93696 | +5187 | +5.86% |
| 7 | Citigroup Inc | $4404961 | 55759 | +50788 | +1021.69% |
| 8 | Franklin Resources Inc | $2299737 | 34207 | +4899 | +16.72% |
| 9 | Bank Of America Corp /De/ | $2197278 | 32683 | -36436 | -52.71% |
| 10 | Bank Of New York Mellon Corp | $1739509 | 25874 | -874 | -3.27% |
| 11 | Nomura Holdings Inc | $1042065 | 15500 | — | NEW BUY |
| 12 | Wells Fargo & Company/Mn | $854227 | 10813 | +3214 | +42.30% |
| 13 | Janus Henderson Group Plc | $228684 | 3400 | — | NEW BUY |
| 14 | Barclays Plc | $112072 | 1667 | — | NEW BUY |
| 15 | Us Bancorp \De\ | $14723 | 219 | +16 | +7.88% |
| 16 | Royal Bank Of Canada | $7000 | 107 | — | NEW BUY |
| 17 | Pnc Financial Services Group, Inc. | $2756 | 41 | — | Held |
| 18 | Fifth Third Bancorp | $1412 | 21 | — | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.